EXCLUSIVE: A top doctor has shared five common symptoms which could be a sign that something is seriously wrong.

ASCO Annual Meeting brought many different updates to light in the realm of hematological malignancies, including multiple ...

Early intervention in high-risk smoldering myeloma with lenalidomide delays progression by up to 7 years and achieves ...

Multiple myeloma — cancer of the white blood cells known as plasma cells — can cause a vast spectrum of symptoms as it progresses. But multiple myeloma often has no outward signs in its early ...

Multiple myeloma accounts for 15 per cent of all blood cancers and in recent years, its prevalence has risen sharply and is ...

Cilta-cel therapy significantly enhances survival rates in lenalidomide-refractory multiple myeloma, outperforming standard ...

If approved, daratumumab will be the first authorised treatment option for patients with smouldering multiple myeloma at high-risk of developing multiple myeloma, offering the potential for disease ...

Per ODAC and CHMP recommendations, subcutaneous daratumumab may become the first approved treatment for smoldering myeloma.

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

The debate between CAR T-cell therapy and bispecific antibodies is not a rivalry but a question of sequencing, ...

A WOMAN left with a broken rib and severe kidney damage after her incurable blood cancer was mistaken for menopause says she ...